Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
AIDS
; 21(2): 231-5, 2007 Jan 11.
Article
en En
| MEDLINE
| ID: mdl-17197815
ABSTRACT
OBJECTIVE:
To compare HIV prevalence among injecting and non-injecting heroin and cocaine users in New York City. As HIV is efficiently transmitted through the sharing of drug-injecting equipment, HIV infection has historically been higher among injecting drug users.DESIGN:
Two separate cross-sectional surveys, both with HIV counseling and testing and drug use and HIV risk behavior questionnaires.METHODS:
Injecting and non-injecting heroin and cocaine users recruited at detoxification and methadone maintenance treatment from 2001-2004 (n = 2121) and recruited through respondent-driven sampling from a research storefront in 2004 (n = 448).RESULTS:
In both studies, HIV prevalence was nearly identical among current injectors (injected in the last 6 months) and heroin and cocaine users who had never injected 13% [95% confidence interval (CI), 12-15%] among current injectors and 12% (95% CI, 9-16%) among never-injectors in the drug treatment program study, and 15% (95% CI, 11-19%) among current injectors and 17% (95% CI, 12-21%) among never injectors in the respondent driven sampling storefront study. The 95% CIs overlapped in all gender and race/ethnicity subgroup comparisons of HIV prevalence in both studies.CONCLUSIONS:
The very large HIV epidemic among drug users in New York City appears to be entering a new phase, in which sexual transmission is of increasing importance. Additional prevention programs are needed to address this transition.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Infecciones por VIH
/
Seroprevalencia de VIH
/
Trastornos Relacionados con Sustancias
Tipo de estudio:
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País como asunto:
America do norte
Idioma:
En
Año:
2007
Tipo del documento:
Article